Systematic review of the complications following isolated calf deep vein thrombosis

British Journal of Surgery

Volumn 103, Issue 7, 2016, Pages 789-796

  Garry, J ^a   Duke, A ^a   Labropoulos, N ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

BLEEDING; CHEMICALLY INDUCED; COMPLICATION; CONSERVATIVE TREATMENT; HUMAN; LEG; PULMONARY EMBOLISM; RECURRENT DISEASE; VASCULARIZATION; VENOUS THROMBOSIS;

ANTICOAGULANTS; CONSERVATIVE TREATMENT; HEMORRHAGE; HUMANS; LEG; PULMONARY EMBOLISM; RECURRENCE; VENOUS THROMBOSIS;

EID: 84963744272     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.10152     Document Type: Review

References (33)

1. Labropoulos N, Webb KM, Kang SS, Mansour MA, Filliung DR, Size GP, et al. Patterns and distribution of isolated calf deep vein thrombosis. J Vasc Surg 1999; 30: 787-791.
2. Mattos MA, Melendres G, Sumner DS, Hood DB, Barkmeier LD, Hodgson KJ, et al. Prevalence and distribution of calf vein thrombosis in patients with symptomatic deep venous thrombosis: a color-flow duplex study. J Vasc Surg 1996; 24: 738-744.
3. Douketis JD, Kearon C, Bates S, Duku EK, Ginsberg JS,. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA 1998; 279: 458-462.
4. White RH,. The epidemiology of venous thromboembolism. Circulation 2003; 107 (Suppl 1): I4-I8.
5. Masuda EM, Kistner RL, Musikasinthorn C, Liquido F, Geling O, He Q,. The controversy of managing calf vein thrombosis. J Vasc Surg 2012; 55: 550-561.
6. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009; 339: b2700.
7. Philbrick JT, Becker DM,. Calf deep venous thrombosis. A wolf in sheep's clothing? Arch Intern Med 1988; 148: 2131-2138.
8. Hull R, Delmore T, Genton E, Hirsh J, Gent M, Sackett D, et al. Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis. N Engl J Med 1979; 301: 855-858.
9. Kakkar VV, Lawrence D,. Hemodynamic and clinical assessment after therapy for acute deep vein thrombosis. A prospective study. Am J Surg 1985; 150: 54-63.
10. Lagerstedt CI, Olsson CG, Fagher BO, Oqvist BW, Albrechtsson U,. Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis. Lancet 1985; 2: 515-518.
11. Schwarz T, Schmidt B, Beyer J, Schellong SM,. Therapy of isolated calf muscle vein thrombosis with low-molecular-weight heparin. Blood Coagul Fibrinolysis 2001; 12: 597-599.
12. Labropoulos N, Kang SS, Mansour MA, Giannoukas AD, Moutzouros V, Baker WH,. Early thrombus remodelling of isolated calf deep vein thrombosis. Eur J Vasc Endovasc Surg 2002; 23: 344-348.
13. Sharpe RP, Gupta R, Gracias VH, Pryor JP, Pieracci FM, Reilly PM, et al. Incidence and natural history of below-knee deep venous thrombosis in high-risk trauma patients. J Trauma 2002; 53: 1048-1052.
14. Ferrara F, Meli F, Amato C, Cospite V, Raimondi F, Novo G, et al. Optimal duration of treatment in surgical patients with calf venous thrombosis involving one or more veins. Angiology 2006; 57: 418-423.
15. Parisi R, Visona A, Camporese G, Verlato F, Lessiani G, Antignani PL, et al. Isolated distal deep vein thrombosis: efficacy and safety of a protocol of treatment. Treatment of Isolated Calf Thrombosis (TICT) Study. Int Angiol 2009; 28: 68-72.
16. Barrellier MT, Lebel B, Parienti JJ, Mismetti P, Dutheil JJ, Vielpeau C,. Short versus extended thromboprophylaxis after total knee arthroplasty: a randomized comparison. Thromb Res 2010; 126: e298-e304.
17. Labropoulos N, Jen J, Jen H, Gasparis AP, Tassiopoulos AK,. Recurrent deep vein thrombosis: long-term incidence and natural history. Ann Surg 2010; 251: 749-753.
18. Schwarz T, Buschmann L, Beyer J, Halbritter K, Rastan A, Schellong S,. Therapy of isolated calf muscle vein thrombosis: a randomized, controlled study. J Vasc Surg 2010; 52: 1246-1250.
19. Singh K, Yakoub D, Giangola P, DeCicca M, Patel CA, Marzouk F, et al. Early follow-up and treatment recommendations for isolated calf deep venous thrombosis. J Vasc Surg 2012; 55: 136-140.
20. Guarnera G, Abeni D, Antignani PL, Apollonia A, Conti F, Mollo PL, et al. Update on distal deep venous thrombosis. Reports of a multicenter study. Int Angiol 2014; 33: 560-564.
21. Horner D, Hogg K, Body R, Nash MJ, Baglin T, Mackway-Jones K,. The anticoagulation of calf thrombosis (ACT) project: results from the randomized controlled external pilot trial. Chest 2014; 146: 1468-1477.
22. Sartori M, Migliaccio L, Favaretto E, Palareti G, Cosmi B,. Two years outcome of isolated distal deep vein thrombosis. Thromb Res 2014; 134: 36-40.
23. Righini M, Galanaud JP, Guenneguez H, Brisot D, Diard A, Faisse P, et al. Anticoagulant therapy for symptomatic distal deep vein thrombosis: the CACTUS randomized placebo-controlled trial. J Thromb Haemost 2015; 13 (Suppl 2): 50.
24. Galanaud JP, Quenet S, Rivron-Guillot K, Quere I, Sacnchez Munoz-Torrero JF, Tolosa C, et al. Comparison of the clinical history of symptomatic isolated distal deep-vein thrombosis vs. proximal deep vein thrombosis in 11 086 patients. J Thromb Haemost 2009; 7: 2028-2034.
25. De Martino RR, Wallaert JB, Rossi AP, Zbehlik AJ, Suckow B, Walsh DB,. A meta-analysis of anticoagulation for calf deep venous thrombosis. J Vasc Surg 2012; 56: 228-237.e1
26. Costantino G, Ceriani E, Rusconi AM, Podda GM, Montano N, Duca P, et al,. Bleeding risk during treatment of acute thrombotic events with subcutaneous LMWH compared to intravenous unfractionated heparin; a systematic review. PLoS One 2012; 7: e44553.
27. Wells PS, Forgie MA, Rodger MA,. Treatment of venous thromboembolism. JAMA 2014; 311: 717-728.
28. Alonso-Coello P, Bellmunt S, McGorrian C, Anand SS, Guzman R, Criqui MH, et al. Antithrombotic therapy in peripheral artery disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (Suppl): e669S-e690S.
29. Palareti G,. How I treat isolated distal deep vein thrombosis (IDDVT). Blood 2014; 123: 1802-1809.
30. Horner D, Hogg K, Body R,. Should we be looking for and treating isolated calf vein thrombosis? Emerg Med J 2015; [Epub ahead of print].
31. Zhu T, Martinez I, Emmerich J,. Venous thromboembolism: risk factors for recurrence. Arterioscler Thromb Vasc Biol 2009; 29: 298-310.
32. Anderson FA Jr, Spencer FA,. Risk factors for venous thromboembolism. Circulation 2003; 107 (Suppl 1): I9-I16.
33. Murin S, Romano PS, White RH,. Comparison of outcomes after hospitalization for deep venous thrombosis or pulmonary embolism. Thromb Haemost 2002; 88: 407-414.